my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Only 90 years have passed since the discovery of the fungal compound effective against bacteria to the production of synthetic antibiotics. During this time, formerly dangerous medical treatments and diseases became possible or curable. The downside of the success of antibiotically active substances is their natural counterpart - evolution. The development of resistance in bacterial strains is the greatest challenge facing 21st century medicine.
Santa Cruz Biotechnology, Inc. is focused on the ongoing development of research antibodies. It is our goal to continue to offer the broadest range of research reagents in the field. We provide superior, innovative primary antibodies and support products. We are the leading worldwide source of prod more
Pricella is a wholly-owned subsidiary of Elabscience. We focus on R&D and production of cell culture media, cell culture auxiliary reagents, cell growth factors, and cell analysis assays. We have always committed to providing professional, efficient, and high-quality products for cell research and c more
To support leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives, that´s the commitment Alna-Bioscience once gave itself and founded is growth. Alna-Bioscience can offer you indi more
Multidrug-resistant bacterial infections that cannot be treated by any known antibiotics pose a serious global threat. In the journal Angewandte Chemie, a Chinese research team has now introduced a method for the development of novel antibiotics to fight resistant pathogens. The drugs are based on p more
Cold Spring Harbor Laboratory (CSHL) chemists have created a new collection of molecular compounds and begun testing them as potential leads in the search for new drugs. Among these molecules, they found several that show promise for development as antibiotics and cancer therapies. Sounds like a eur more
Even if they attack the same target in the bacterial cell, the cellular response to different antibiotics can vary. There is an urgent need for new antimicrobial strategies to keep pathogens in check. This applies specifically to Gram-negative bacteria, which are protected from antibiotic interventi more
On more than 200 pages the new Fisher BioReagents Handbook 2010 contains more than 1,200 bioreagents for Nucleic Acid Electrophoresis, Purification, Hybridization, and Sequencing Polymerase Chain Reaction (PCR) Protein Purification and Electrophoresis Buffers and Detergents Cell Biology/Cell Cu ... more
When we’re suffering from a bacterial infection, a trip to the doctors to be prescribed antibiotics is commonplace. However, there are a wide range of antibiotics available, and they vary both in their usage and their mechanism of action. This graphic summarises the major classes, and also gives a b more
This is a series of graphics looking at the chemistry and uses of some everyday chemical compounds you can find in a variety of products around your home. The series was inspired by conversation with@chemtacular on twitter, as well as the ongoing chemophobia discussion. To kick off the series, this more
If you’ve read any science news over the past day or so, you’ll have noticed it’s been dominated by stories about the discovery of a new antibiotic, teixobactin. There’s a reason that the scientific community is so excited by its discovery, but in truth, it’s the method which was used to discover it more
Production of antibiotics The production of antibiotics has been widespread since the pioneering efforts of Florey and Chain in 1939 . The importance of antibiotics to medicine has led to much research into discovering and producing them. I ... more
Watchlist
This is where you can add this topic to your personal favourites
© 1997-2024 LUMITOS AG, All rights reserved
